Wilson’s Disease Special Interest Group
Wilson’s Disease Special Interest Group (SIG)
The Wilson’s Disease Special Interest Group (SIG) is the first SIG to be established by BASL. It is linked to the Metabolic CRN topic area. The SIG Lead is Dr Bill Griffiths of Addenbrookes Hospital, Cambridge. The Wilson’s SIG comprises a variety of clinical and laboratory specialists from around the UK, Public Health England and patient representation from the Wilson’s Disease Support Group. Its aims are to foster closer collaboration for clinical and scientific research, provide a forum to discuss and disseminate best practice, and act as a stimulus towards Centres of Excellence for Wilson’s disease. The group has met twice thus far in December 2017 and June 2018. Reports from those meetings will be made available along with presentation slides. If anyone wishes to join the group please contact the BASL secretariat on Samantha@basl.org.uk.
Annual report 2017-18 - Download Annual report_2017-18_Wilsons Disease SIG.pdf.
1st meeting - 14 December 2017
Meeting report - Download BASL Wilson SIG Meeting 14 Dec 2017 Report1.pdf
2nd meeting - 14 June 2018
Meeting report - Download BASL Wilson SIG meeting 14 June report.pdf
Presentation on DNA/RNA therapies for Wilson’s Disease, Julien Baruteau, UCL - Download Baruteau_Gene therapy for Wilson.2.pdf
Presentation on biochemical monitoring, Paul Cook, University Hospital Southampton - Download Biochemical monitoring.pdf
Presentation on measurement techniques, Chris Harrington, SAS Trace Element Laboratory, Guildford - Download BASL-June 2018-web.pdf
Presentation on Wilson’s Disease in children, Professor Deirdre Kelly, Dr Indra van Mourik and Carla Lloyd, Birmingham Women’s & Children’s Hospital - Download Wilsons Disease in children.pdf
Presentation on paediatric specific issues for Wilson's Disease screening and monitoring, Dr Indra van Mourik, Birmingham Women’s & Children’s Hospital - Download Paediatric specific issues for Wilsons Disease screening and monitoring.pdf